For investors seeking a strong dividend player, there are some market segments that are known for their high-yield dividends, making them logical places to start looking for reliable payers. The
For investors seeking a strong dividend player, there are some market segments that are known for their high-yield dividends, making them logical places to start looking for reliable payers. The
Should you call GameStop’s (GME) astounding run-up this month amazing, or ridiculous? Perhaps “amazingly ridiculous” is a reasonable compromise. From Jan. 4, the first trading day of the New Year,
The biotech sector has started the year with a bang. The industry benchmark, iShares NASDAQ Biotechnology ETF (IBB), is up ~11% so far in January — far better than the S&P 500’s 3% return.
Some companies favor a “do one job and do it well” approach. However, that is not the Sorrento Therapeutics (SRNE) way. While being laser-focused on just one objective can have
To say it is all coming together nicely for Bionano Genomics (BNGO) would be a bit of an understatement. The life sciences company’s rise has been particularly eye-catching; Over the
